Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-7479d7b7d-rvbq7 Total loading time: 0 Render date: 2024-07-11T14:18:52.449Z Has data issue: false hasContentIssue false

12 - Therapeutic decision making in BMT/SCT for nonseminomatous germ cell tumor of testis

Published online by Cambridge University Press:  05 August 2013

By
Reinhold Munker ,
Hillard M. Lazarus  and
Kerry Atkinson
Edited by
Reinhold Munker ,
Gerhard C. Hildebrandt ,
Hillard M. Lazarus  and
Kerry Atkinson
Reinhold Munker
Affiliation:
Louisiana State University, Shreveport
Gerhard C. Hildebrandt
Affiliation:
University of Utah
Hillard M. Lazarus
Affiliation:
Ireland Cancer Center, Case Western Reserve University Hospital, Cleveland
Kerry Atkinson
Affiliation:
University of Queensland
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The BMT Data Book
Including Cellular Therapy
 , pp. 139 - 145
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Beyer, J, Kramar, A, Mandanas, R, et al. 1996. High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. J Clin Oncol 14: 2638–2645.CrossRefGoogle ScholarPubMed
Connolly, RM & McCaffrey, JA. 2009. High-dose chemotherapy plus stem cell transplantation in advanced germ cell cancer: a review. Eur Urol 56: 57–64.CrossRefGoogle ScholarPubMed
Daugaard, G, Skoneczna, I, Aass, N, et al. 2011. A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974). Ann Oncol 22: 1054–1061.CrossRefGoogle Scholar
De Giorgi, U, Papiani, G, Severini, G, et al. 2003. High-dose chemotherapy in adult patients with germ cell tumors. Cancer Control 10: 48–56.CrossRefGoogle ScholarPubMed
Einhorn, EH. 1997. Testicular cancer: an oncological success story. Clin Cancer Res 3: 2630–2632.Google ScholarPubMed
Einhorn, LH, Williams, SD, Chamness, A, et al. 2007. High-dose chemotherapy and stem cell rescue for metastatic germ-cell tumor. N Engl J Med 357: 340–348.CrossRefGoogle Scholar
IGCCCG: 1997. International Germ Cell Consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15: 594–603.CrossRefGoogle Scholar
Jones, RH & Vasey, PA. 2003. Testicular cancer-management of advanced disease. Lancet Oncol 4: 738–747.CrossRefGoogle ScholarPubMed
Lazarus, HM, Stiff, PJ, Carreras, J, et al. 2007. Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a Center for International Blood and Marrow Transplantation Research (CIBMTR) analysis. Biol Blood Marrow Transplant 13: 778–789.CrossRefGoogle ScholarPubMed
Motzer, RJ, Nichols, CJ, Margolin, KA, et al. 2007. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. J Clin Oncol 25: 247–256.CrossRefGoogle ScholarPubMed
Sonneveld, DJ, Hoekstra, HJ, van der Graaf, WT, et al. 2001. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era. Cancer 91: 1304–1315.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
Sonpavde, G, Hutson, TE, Roth, BJ. 2007. Management of recurrent testicular germ cell tumors. Oncologist 12: 51–61.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×